Australian researchers have discovered a previously unknown rogue immune cell that can cause poor antibody responses in chronic viral infections.
Clinical Challenges: Is Recalcitrant Atopic Dermatitis Really Comorbid Disease?
Recent evidence indicates that a significant percentage of patients with recalcitrant eczematous dermatitis, including those dubbed “treatment-resistant” to dupilumab (Dupixent), may be living with a
November 9, 2023